Learn More
Invitrogen™ Melan-A Recombinant Rabbit Monoclonal Antibody (SC56-02)
Rabbit Recombinant Monoclonal Antibody
Supplier: Invitrogen™ MA532217
Description
Recombinant rabbit monoclonal antibodies are produced using in vitro expression systems. The expression systems are developed by cloning in the specific antibody DNA sequences from immunoreactive rabbits. Then, individual clones are screened to select the best candidates for production. The advantages of using recombinant rabbit monoclonal antibodies include: better specificity and sensitivity, lot-to-lot consistency, animal origin-free formulations, and broader immunoreactivity to diverse targets due to larger rabbit immune repertoire.
MART1 is involved in melanosome biogenesis by ensuring the stability of GPR143. Plays a vital role in the expression, stability, trafficking, and processing of melanocyte protein PMEL, which is critical to the formation of stage II melanosomes.
Specifications
Melan-A | |
Recombinant Monoclonal | |
1 mg/mL | |
TBS with 0.05% BSA, 40% Glycerol and 0.05% sodium azide; pH 7.4 | |
Q16655 | |
MLANA | |
Synthetic peptide within Human MelanA aa 2-43. | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG |
Immunohistochemistry, Immunohistochemistry (Paraffin), Western Blot, Western Blot | |
SC56-02 | |
Unconjugated | |
MLANA | |
A930034P04Rik; Antigen LB39-AA; antigen SK29-AA; MART1; MART-1; melan-A; melanoma antigen recognized by T-cells 1; melanoma associated antigen recognized by T-cells 1; MLANA; Protein Melan-A | |
Rabbit | |
Protein A | |
RUO | |
2315 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Your input is important to us. Please complete this form to provide feedback related to the content on this product.